Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 991 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Search Again
 Back
 Table of Contents
 
 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Article Access Statistics
 Reader Comments
 Email Alert
 Add to My List
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed558    
    Printed27    
    Emailed0    
    PDF Downloaded52    
    Comments [Add]    

Recommend this journal

 
ARTICLE
Year : 1999  |  Volume : 41  |  Issue : 4  |  Page : 325-328

A Comparative Efficacy Study of Centbutindole and Haloperidol in Schizophrenia


1 Professor, Department of Psychiatry, K.G.'s Medical College, Lucknow, India
2 Scientist, Division of Cinical & Experimental Medicine, C.D.R.I., Lucknow, India
3 Professor, Department of of Psychiatry, KG's Medical College, Lucknow, India
4 Head, Division of Cinical & Experimental Medicine, C.D.R.I., Lucknow, India

Correspondence Address:
Harjeet Singh
Professor, Department of Psychiatry, K.G.'s Medical College, Lucknow
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 21430805

Rights and PermissionsRights and Permissions

A double blind study was undertaken to compare the efficacy between centbutindole and haloperidol. A total of 44 patients suffering from schizophrenia diagnosed in accordance to ICD-10 criteria were included. They were randomly assigned into two groups receiving centbutindole (4.5 mg) or haloperidol (15 mg) in two divided doses per day for six weeks. Each patient was evaluated on Positive and Negative Syndrome Scale (PANSS), Clinical Global Impression Scale (CGI-S) and UKU side effect scale every week. Five patients (1 patient in centbutindole group, 4 patients in haloperidol group) dropped out due to various reasons. A total of 39 patients (21 patients in centbutindole group and 18 patients in haloperidol group) completed the study. The results revealed an early onset of therapeutic effect with centbutindole for both positive and negative symptoms. However, the efficacy was comparable between centibutindole and haloperidol from 3rd week onwards.



[PDF]*

        

Print this article         Email this article